SCHEMBL22909466

SCHEMBL22909466

CN(C)S(=O)(=O)c1c(F)c(F)c(F)c(F)c1Cc1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC11 Q96DB2 2/20 0.39
HDAC8 Q9BY41 2/20 0.39
HDAC6 Q9UBN7 2/20 0.39
CA12 O43570 5/20 0.38
CA1 P00915 5/20 0.38
CA2 P00918 5/20 0.38
CA7 P43166 5/20 0.38
CA13 Q8N1Q1 5/20 0.38
CA9 Q16790 1/20 0.37
TSHR P16473 1/20 0.37
USP2 O75604 1/20 0.37
HPGD P15428 1/20 0.37
HSD17B10 Q99714 1/20 0.37
ALDH1A1 P00352 3/20 0.37
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
TP53 P04637 1/20 0.36
TNF P01375 1/20 0.36
NOD1 Q9Y239 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22909381 0.82 TSHR (0.42) HDAC11HDAC8HDAC6CA12CA1
SCHEMBL22909578 0.75 CA2 (0.61) HDAC11HDAC8HDAC6CA12CA1
SCHEMBL22909165 0.75 CA12 (0.61) HDAC11HDAC8HDAC6CA12CA1
SCHEMBL22909373 0.75 AR (0.45) HDAC11HDAC8HDAC6CA12CA1
SCHEMBL29729072 0.74 CA1 (0.33) HDAC11HDAC8HDAC6CA12CA1
SCHEMBL22909481 0.74 CA1 (0.33) HDAC11HDAC8HDAC6CA12CA1
SCHEMBL17113782 0.73 CA2 (0.61) CA12CA1CA2CA7CA13
SCHEMBL15104760 0.73 CALM1 (0.55) TSHRALDH1A1TP53KDM4E
SCHEMBL22909478 0.73 HDAC6 (0.34) HDAC11HDAC8HDAC6CA12CA1
SCHEMBL29671218 0.73 HDAC6 (0.34) HDAC11HDAC8HDAC6CA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12559454-B2 Benzenesulfonamide derivatives and uses thereof 2692372 ONTARIO, INC. (CA) 2026-02-24 US disclosed
US-20220281812-A1 BENZENESULFONAMIDE DERIVATIVES AND USES THEREOF 2692372 ONTARIO INC (CA) 2022-09-08 US disclosed
CN-114502533-A Benzenesulfonamide derivatives and use thereof 2692372安大略公司 2022-05-13 CN disclosed
WO-2021009568-A1 BENZENESULFONAMIDE DERIVATIVES AND USES THEREOF 2692372 ONTARIO, INC. (CA) 2021-01-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12559454-B2 Benzenesulfonamide derivatives and uses thereof NR2E1, NR2C2, NR3C1 HDAC11 1733/4885HDAC8 2150/4885HDAC6 1241/4885
US-20220281812-A1 BENZENESULFONAMIDE DERIVATIVES AND USES THEREOF BCR, ARSA, VHL HDAC11 2800/4885HDAC8 3151/4885HDAC6 549/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.